Biographies

Mr. Philippe Charrier has served as Chairman of the Board of Orpea SA, since March 28, 2017. He is a graduate of the Hautes Etudes Commerciales, is a highly experienced healthcare and consumer products executive. He is currently Executive Chairman of Ponroy Santé, a European group specializing in natural health products for consumers. Previously, he was CEO of Labco from 2011 to 2015, then Executive Chairman until 2016. From 2006 until 2010, he was CEO of Oenobiol, a European specialist in food supplements for health and beauty. Prior to that, he was CEO of Procter & Gamble France for seven years. He was also Chairman of the Supervisory Board of Spotless until 2010 and a director of Lafarge until 2016. He is currently a director of Rallye and MédiPôle Partenaire. Separately, he is the founder and Chairman of Clubhouse France, a not-for-profit organization helping vulnerable people with mental health conditions to forge stronger social ties and find employment.

Mr. Yves Le Masne has served as Chief Executive Officer, Financial Director, Member of the Executive Committee and Director of Orpea SA as of February 15, 2011. Prior to February 15, 2011, he was Deputy Chief Executive Officer, Financial Director, Member of the Executive Committee and Director of Orpea SA from 2006. He joined the Company in 1993 as a Management Controller and was then appointed as Administrative and Financial Director of the Company in 1998. Prior to working for Orpea SA, he was an Engineer specialized in IT management focused on finance and management control. He also holds other mandates, including Chairman of Clinea SAS and President or Manager of various other subsidiaries of the Company. He holds a Postgraduate degree in Finance and Accounting and also graduated from Universite Paris I Pantheon Sorbonne and from Ecole Superieure d'Informatique de Gestion (ESIG).

Mr. Jean-Claude Brdenk has served as Chief Operating Officer at Orpea SA since March 25, 2013. He has been with the Group for over 20 years, after graduating from business school (ISIG – international management cycle). In 1997, he joined the Group in an operational management role. In 2011, he was appointed Chief Operating Officer of ORPEA, responsible for assisting the Chief Executive Officer with managing the Group’s facilities, for the latter’s term in office. In 2013, he was appointed as Chief Executive Officer of CLINEA SAS, a wholly-owned subsidiary of ORPEA, which manages healthcare facilities, rehabilitation hospitals and psychiatric hospitals. His current offices helld within the Group include Director, Chairman and Chief Executive Officer: Clinique L’Émeraude; Director: Les Charmilles, Clinique Regina; Chairman: Clinique du Parc de Belleville, La Jonchère nursing home; Chief Executive Officer: CLINEA; Manager: Cuxac, La Pastorale.

Ms. Sophie Kalaidjian has served as Director, Employee Representative at Orpea SA, since 2015. A lawyer by training, Ms. Kalaidjian has been an employee in the Group for nearly 12 years. She currently has the duties of CLINEA Legal Director and in that capacity is involved in developing and monitoring compliance by the Group’s clinics with the legislation for post-acute and psychiatric operations. With her familiarity with the Group, she brings added insight to the Board discussions.

Ms. Brigitte Lantz has served as Director of Orpea SA, since June 14, 2016. She is a nephrology specialist. She graduated from the Paris Faculty of Medicine, is a practicing hospital physician at Necker hospital and holds a postgraduate DEA degree in endocrinology. Since 2007, Brigitte has been an advisor to the Director-General of Assistance Publique–Hôpitaux de Paris public hospital authority for the Paris region. She is also a member of the steering committee on renal failure and dialysis established by the French ministry for social and health affairs’ care provision directorate-general. Between 2002 and 2012, Brigitte advised several health ministers (Jean-François Mattei, Philippe Douste-Blazy, Xavier Bertrand) and conducted special assignments for Roselyne Bachelot and François Fillon. Brigitte also served as a government commissioner in 2002, working on the decrees introducing a framework for dialysis in France. Between 1997 and 2002, she was a technical advisor to the Head of Hospitals (Claire Bazy-Malaury), then medical advisor to the Director-General of the Hospital System and Care (Édouard Couty). Prior to that between 1991 and 1997, Brigitte worked in dialysis clinics as an independent physician. From 1979 until 1991, she was international project leader for the Servier pharma group. Brigitte is also General Secretary of the French kidney foundation and the Princess Margareta of Romania charitable foundation in France. In addition, she has published various books on medicine.

Ms. Laure Baume is Independent Director of Orpea SA. She was first appointed Member of the Company's Board of Directors on June 14, 2016. Since September 26, 2017 she has been Member of the Company's Audit Committee. She is a graduate of the HEC Paris business school, was appointed as Executive Director, Director of Aeroports de Paris Customer Division in 2014. She is also a member of its Executive Committee. Since 2015, she has also sat on the Executive Committee of the Distribution Aéroportuaire, Relay@adp and EPIGO joint ventures within the Aéroports de Paris group. She joined ORPEA as a director on 14 December 2016. Laure was Club Méditerranée’s Marketing Director for France and then Switzerland from 2006 onwards. She was subsequently appointed to the General Management Committee of Club Med as General Manager of the New Markets – Europe-Africa and Strategic Marketing Business Unit. Laure’s career began with US group Kraft Foods (since renamed Mondelez), where she held a series of positions including product manager, category head and brand manager in Paris and New York.

Mr. Xavier Coirbay has held the position of Independent Director of Orpea SA since June 22, 2017. Since September 26, 2017 he has been Member of the Nomination and Remuneration Committee of the Company. He is currently a member of SOFINA’s Executive Committee and has responsibility for the SOFINA group’s investments in hedge funds and growth co-investments. He is also leading SOFINA’s expansion into the United States and Asia, which includes supervising the Singapore office. Prior to joining SOFINA in 1992, he had begun his career as a financial analyst in the asset management department of Générale de Banque, which has since joined the BNP group. He graduated from the Solvay business school in Brussels (1988), where he also gained a master’s degree in the management of tax affairs (1990).

Ms. Bernadette Danet-Chevallier has served as Independent Director at Orpea SA, since 2014. She is Member of the Company's Remuneration and nomination Committee. She has spent the greater part of her career in the tourism and hospitality industries. She has held successive management positions in finance, revenues and marketing at Club Mediterranee, then in the Accor Group and later in senior management in the independent lodging industry.

Mr. Jean-Patrick Fortlacroix has served as Independent Director of Orpea SA since June 30, 2011. He is Chairman of the Company's Audit Committee. He is a qualified chartered accountant with a postgraduate DESS degree in banking and finance and a master’s degree in accounting and finance. As a chartered accountant and Statutory Auditor, he possesses genuine expertise in real estate, taxation and consolidation, particularly in the healthcare and nursing home sectors. His currently held offices outside the GRoup include Chairman: Add Equation and Manager: Cadeco.

Mr. Christian B. Hensley is Independent Director of Orpea SA. He was first appointed Member of the Company's Board of Directors on June 23, 2016. Since September 26, 2018 he has been Member of the Company's Nomination and Remuneration Committee. He began his career with the investment services division of Salomon Brothers in New York. Subsequently, he spent 11 years working in the private equity and growth capital industry at Charterhouse Group and Planier Capital. In 2012, he was appointed as Senior Principal of Relationship Investments at Canada Pension Plan Investment Board (CPPIB). He holds a degree from the University of Pennsylvania and an MBA from Harvard Business School. He sits on the Board of Directors of 21st Century Oncology. In the past, he has also been a director of five companies active in business services, healthcare, communications and education.

Mr. Thierry Mabille de Poncheville has served as Independent Director, Permanent Representative of FFP Invest at Orpea SA since February 15, 2012. He is also Chairman of the Nominating and Remuneration Committees, as well as Member of the Audit Committee of the Company. He previously was Independent Director, Permanent Representative of FFP at the Company from October 17, 2011. He is a Director of Groupe PSA SA and SICAV MO Select.

Ms. Joy Verle has served as Independent Director of Orpea SA, since April 27, 2017. Since September 26, 2017 she has been Member of the Company's Audit Committee. She joined Canada Pension Plan Investment Board (CPPIB) in 2016 as Principal in Relationship Investments, making investments in listed companies and companies soon to be listed. After graduating from HEC Paris business school in 2003, she initially worked in M&A and capital markets activities for Morgan Stanley. In 2006, she moved to the Bregal Capital fund where she led private equity transactions in the education, renewable energies and healthcare sectors as partner. She has also held directorships in three companies active in the education and renewable energies sectors.

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: